Table 3 Characteristics of patient’s cohort.
Numbers of pts (total pts) | Median (range) | ||
|---|---|---|---|
Responders | 8 (16) | ||
Non responders | 8 (16) | ||
mHSPC | 1 (16) | ||
mCRPC | 15 (16) | ||
Age (year) | 16 (16) | 75 (56–84) | |
Status | alive | 9 (16) | |
dead | 7* (16) | ||
PSA (μg/l) | before DCT | 16 (16) | 29.075 (0.33–693) |
after DCT | 15 (16) | 27.27 (0.21–832) | |
Gleason at diagnosis | <7 | 0 (16) | |
=7 | 4 (16) | ||
>7 | 12 (16) | ||
Metastasis | bone only | 4 (16) | |
bone, visceral | 2 (16) | ||
bone, nodal | 6 (16) | ||
bone, nodal, visceral | 4 (16) | ||
Subsequent treatments | abiraterone | 1 (16) | |
cabazitaxel | 1 (16) | ||
enzalutamide | 2 (16) | ||
radiotherapy | 1 (16) | ||
none | 7 (16) | ||
unknown | 3 (16) |
